Cases & Deals

Publicly traded life sciences company conducts FCPA investigation of China whistleblower allegations and assessment of local government enforcement action

Clients Publicly traded life sciences company

Jones Day assisted a publicly traded life sciences company with its investigation of allegations that senior management in China helped distributors evade the company's anti-corruption controls in potential violation of the FCPA. Jones Day further advised the company regarding potential FCPA liability arising from Chinese government enforcement actions alleging violations of local anti-corruption laws.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.